Kherallah, Kenan
Chung, Claire S.
Ghanshani, Raveena
Charrow, Alexandra
Riley, Julia M.
Sayed, Christopher J.
Shi, Vivian Y.
Lee, Katrina H.
Hsiao, Jennifer L.
Article History
Received: 10 October 2025
Accepted: 10 November 2025
First Online: 24 November 2025
Declarations
:
: Kenan Kherallah, Claire S. Chung, and Raveena Ghanshani have nothing to disclose. Alexandra Charrow is on the board of the HSF, has served on advisory boards for Novartis, BCG, Incyte, and Avalo. She is an investigator for studies with Sonoma, Incyte, Insmed, and Avalo. Julia M. Riley has served as an investigator for AbbVie, Novartis, Moonlike, and Incyte. Christopher J. Sayed has been a speaker for Abbvie, Novartis, and UCB, consultant for AbbVie, Novartis, UCB, Incyte, InflaRx, Astrazeneca, Alumis, Sonoma Biotherapeutics, Cantargia, Navigator Medicines, Elasmogen, Sanofi, Sandoz, Moonlake Therapeutics, and an investigator for Novartis, UCB, Incyte, InflaRx, Astrazeneca. Vivian Y. Shi is on the board of directors for the Hidradenitis Suppurativa Foundation (HSF), an advisor for the National Eczema Association, is a stock shareholder of Learn Health and has served as an advisory board member, investigator, speaker, and/or received research funding from Sanofi Genzyme, Regeneron, AbbVie, Genentech, Eli Lilly, Novartis, SUN Pharma, LEO Pharma, Pfizer, Incyte, Dermavant, Apogee, MoonLake, Navigator Medicine, Boehringer Ingelheim, Almirall, Alumis, Aristea Therapeutics, Menlo Therapeutics, Dermira, Burt’s Bees, Galderma, Kiniksa, UCB, Ceraclere, Bain Capital, Target-PharmaSolutions, Castle Bioscience, Altus Lab/cQuell, MYOR, Polyfins Technology, GpSkin and Skin Actives Scientific. Katrina H. Lee has served as an investigator or advisor for Novartis, Incyte. The other authors have no other conflicts to disclose. Jennifer L. Hsiao is on the board of directors for the HS Foundation, and has served as an advisor, investigator, and/or speaker for AbbVie, Amgen, Aclaris, AstraZeneca, Boehringer Ingelheim, Galderma, Incyte, Moonlake, Navigator Medicines, Novartis, Pfizer, Sanofi, Regeneron, UCB. Jennifer L. Hsiao is an Editorial Board member of Dermatology and Therapy. Jennifer L. Hsiao was not involved in the selection of peer reviewers for the manuscript nor any of the subsequent editorial decisions.
: This review is based on previously conducted studies and does not contain any new studies with human participants or animals performed by any of the authors.